A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season

Vaccine

Volumn 30, Issue 42, 2012, Pages 6099-6102

  Tennis, Patricia ^a   Toback, Seth L ^b   Andrews, Elizabeth B ^a   McQuay, Lisa J ^a   Ambrose, Christopher S ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b MEDIMMUNE   (United States)

Author keywords

Asthma; Children; Immunocompromised; Live attenuated influenza vaccine; Trivalent inactivated influenza vaccine; Wheezing

Indexed keywords

INFLUENZA VACCINE; TRIVALENT INACTIVATED INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHIOLITIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROUP; DRUG SAFETY; EMERGENCY WARD; FREQUENCY ANALYSIS; HUMAN; IMMUNOCOMPETENCE; INFANT; INFECTION CONTROL; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; NEWBORN; PNEUMONIA; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; UNITED STATES; WHEEZING;

ASTHMA; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; IMMUNOCOMPETENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PRODUCT SURVEILLANCE, POSTMARKETING; RESPIRATORY SOUNDS; UNITED STATES; VACCINATION; VACCINES, ATTENUATED;

EID: 84865555597     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.031     Document Type: Article

References (12)

1. Belshe R.B., Ambrose C., Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine 2008, 26:D10-D16.
2. Tennis P., Toback S.L., Andrews E., McQuay L.J., Ambrose C.S. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years. Vaccine 2011, 29:4947-4952.
3. Rothman K. Epidemiology, an introduction 2002, Oxford University Press, New York.
4. Bundy D.G. Hospitalizations with primary versus secondary discharge diagnoses of asthma: implications for pediatric asthma surveillance. J Pediatr 2007, 150:446-449. 9 e1.
5. Toback S.L., Herley J., Edelman L., Ambrose C.S. Trends in U.S. pediatric influenza vaccination from 2006 to 2010 among children with private insurance. Vaccine 2011, 29:4225-4229.
6. Esposito S., Marchisio P., Bosis S., Lambertini L., Claut L., Faelli N., et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 2006, 24:629-635.
7. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356:685-696.
8. Barrueto L., Mallol J., Figueroa L. Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing. Pediatr Pulmonol 2002, 34:52-57.
9. Lehtinen P., Ruohola A., Vanto T., Vuorinen T., Ruuskanen O., Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007, 119:570-575.
10. Lombardi E., Morgan W.J., Wright A.L., Stein R.T., Holberg C.J., Martinez F.D. Cold air challenge at age 6 and subsequent incidence of asthma. A longitudinal study. Am J Respir Crit Care Med 1997, 156:1863-1869.
11. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005, 171:137-141.
12. Teper A.M., Kofman C.D., Szulman G.A., Vidaurreta S.M., Maffey A.F. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med 2005, 171:587-590.